Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-20-003117
Filing Date
2020-11-25
Accepted
2020-11-25 16:11:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13da212566zan_11242020.htm SC 13D/A 98435
  Complete submission text file 0000921895-20-003117.txt   99895
Mailing Address MAKY ZANGANEH & ASSOCIATES 51 ADAM WAY ATHERTON CA 94027
Business Address
Zanganeh Maky (Filed by) CIK: 0001507650 (see all company filings)

Type: SC 13D/A

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Subject) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88759 | Film No.: 201350710
SIC: 2834 Pharmaceutical Preparations